FDA clears Siemens SOMATOM Drive CT system

By Staff News Brief
0  Votes

Image Gallery

Siemens Healthineers has announced that the FDA has cleared the SOMATOM Drive computed tomography (CT) system. This new dual-source scanner is designed to drive precision in diagnostic imaging across a wide range of clinical disciplines – from pediatrics and emergency medicine to cardiology and oncology – as well as deliver a new level of quality in patient with the potential to reduce examination time, preparation, and follow-up care.

“Siemens Healthineers is proud to introduce the high-performance SOMATOM Drive dual source CT system, which provides our customers with the flexibility to deliver more precise imaging – and potentially further reduce patient dose through the utilization of multiple KV settings,” says Douglas Ryan, vice president of Computed Tomography at Siemens Healthineers North America.

The SOMATOM Drive CT system is equipped with the new Straton MX Sigma X-ray tubes and Sigma generators, which allow for more targeted beam focusing and enable examinations using high energy levels at low voltages. These lower voltages may allow clinicians to use less contrast, which can be burdensome for patients who are seriously ill or have reduced kidney function. And because the X-ray tube voltages of the SOMATOM Drive are adjustable in 10 kV increments ranging from 70 kV to 140 kV, clinicians can tailor the voltage and, therefore, the dose to each patient. Scanning at a lower kV level reduces patient radiation exposure.>

This technology helps enable CT lung scans to be performed at an extremely low dose, which could prove beneficial for lung cancer screening. With this combination of low doses and high diagnostic reliability, the SOMATOM Drive is also ideal for spinal diagnostics and orthopedic examinations. Additionally, the scanner’s dual energy mode can help clinicians accurately differentiate between tissue and bone.

Patient and user advantages

The speed of the SOMATOM Drive CT system supports pediatric CT examinations with no sedation. In addition, the system’s Stellar Infinity detector and integrated iterative reconstruction capabilities, coupled with the use of very low kV levels, support an environment where the lowest doses are used for pediatric patients.>

Elderly patients who present to the hospital with undiagnosed chest pain and breathing difficulties are among the patient populations who can benefit from the ability to breathe freely during scanning with the SOMATOM Drive. And thanks to the system’s ultra-fast scanning speed, the patient’s heart and lung movement does not compromise diagnostic imaging quality. Further, since a cardiac scan can be performed in one heartbeat using the SOMATOM Drive, beta-blockers may no longer be required to slow the heartbeat of some patients.

These patient benefits also may lead to smoother workflows in the radiology department. If the clinical images from the first CT scan are of diagnostic quality, multiple scans are not necessary. For most patients with reduced kidney function, a lower dose of contrast media may reduce the need for related preparation and follow-up. And since the scanner supports the potential to preform CT examinations with no sedation, anesthetic support and additional intensive medical care may not be required.

Back To Top

FDA clears Siemens SOMATOM Drive CT system .  Appl Rad Oncol. 

By Staff News Brief| September 13, 2016
Categories:  Technologies|Section

About the Author

Staff News Brief

Staff News Brief

 



Copyright © Anderson Publishing, Ltd

 2017